Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Nigeria

Strategic Focus

Active and Strategic Scale-up of Comprehensive HIV Services
CDC’s HIV/AIDS office in Nigeria was launched in February 2001. In accordance with PEPFAR Nigeria’s strategic shift, CDC provides technical leadership and assistance to the Ministry of Health (MOH) and implementing partners to strategically scale up HIV testing, treatment and care, and prevention of mother-to-child transmission of HIV (PMTCT) services. CDC continues to implement activities to reach key populations in focal states with high prevalence and burden of HIV.

Strengthening Laboratory Systems and Networks
CDC provides technical leadership and assistance to build in-country capacity for high-quality national laboratory services and systems to assist with the rapid expansion of HIV treatment, diagnosis, and care as well as serve as a foundation for a national reference lab for TB and other diseases.

Strengthening Public Health Systems
CDC provides technical leadership and direct assistance to the MOH to strengthen epidemiology, surveillance, laboratory, blood safety, operations research, and workforce capacity –essential components for a strong, sustainable public health system.

Key Activities and Accomplishments

Prevention of Mother-to-Child HIV Transmission (PMTCT) Support
Through PEPFAR, CDC has worked with health facilities’ staff and nine local partners to establish 3,367 sites offering PMTCT services across Nigeria. Between October 1, 2012 and September 30, 2013, CDC-Nigeria and its partners provided HIV testing and counseling to over 1.2 million pregnant women and antiretroviral therapy (ART) to 31,732 HIV-positive pregnant women to prevent mother-to-child transmission of HIV (over the one year period).

Antiretroviral Therapy Services
CDC provides ART and other HIV/AIDS services to eligible patients as well as laboratory support for diagnosis and monitoring of HIV-positive patients. With CDC support, 79,282 HIV-positive people were initiated on lifelong ART during FY2013; the total number of people currently receiving antiretroviral treatment has grown overall from 13,000 in 2004 to over 350,000 in FY2013.

TB/HIV Integration
CDC-Nigeria continues to provide technical guidance to its partners to ensure that TB/HIV collaborative activities are strengthened. Between October 1, 2012 and September 30, 2013, CDC Nigeria and its partners have screened about 320,000 people living with HIV/AIDS for TB, with 86,651 TB suspect identified and 21,111 of these confirmed as TB cases out of which 8,600 TB/HIV co-infected patients were placed on TB treatment.

Care and Support 
CDC-Nigeria, through its partners, provides quality HIV care and support services to people living with HIV, both pre-ART and those on ART. In FY13 (October 1, 2012 to September 30, 2013) 575,137 patients including children received a minimum of one clinical service, while over 1.95 million were provided with a minimum of one care service, including OVC services.

HIV Testing and Counseling (HTC) Services 
CDC-Nigeria has worked with nine local partners in Nigeria’s 36 states and Federal Capital Territory to train over 3.5 million health care providers in HIV testing and counseling since 2005. Between October 1, 2012 and September 30, 2013, CDC-Nigeria and its partners provided HIV testing and counseling to over 4.7 million people across Nigeria (over the one year period).

Success Stories

 
Learn how CDC fights global HIV/AIDS
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    24 Hours/Every Day
  • cdcinfo@cdc.gov
  • Page last reviewed: April 13, 2015
  • Page last updated: April 13, 2015
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO